Home LiteratureArticle Details
PMID: 18289041 Published · ppublish English Journal Article Review

p53 Family isoforms.

Current pharmaceutical biotechnology ·Vol. 8 ·No. 6 ·2007-12-00 ·Pages 332-6

Bourdon JC

Abstract

p63, p73 and p53 are transcription factors members of the p53 gene family involved in development, differentiation and cell response to stress. p53 gene is mutated in 50% of human cancer. Moreover, when p53 gene is not mutated then its tumour suppressor pathway is lost through interaction with abnormally expressed cellular protein or viral protein. Therefore p53 pathway inactivation is a common denominator to cancer. However, it is still difficult to associate in the clinic p53 status to cancer prognosis and diagnosis. Recent publications may have a profound impact on our understanding of p53 tumour suppressor activity. p63, p73 and p53 genes have a dual gene structure conserved in drosophila, zebrafish and man. They encode for multiple p63, p73 or p53 proteins containing different protein domains (isoforms) due to multiple splicing, alternative promoter and alternative initiation of translation. The interplay between p53, p63 and p73 isoforms are likely to be fundamental to our understanding of tumour formation.

MeSH Terms
Animals DNA-Binding Proteins/genetics,metabolism Genes, Tumor Suppressor Genes, p53 Humans Mutation Neoplasms/genetics Nuclear Proteins/genetics,metabolism Protein Isoforms Trans-Activators/genetics,metabolism Transcription Factors Tumor Protein p73 Tumor Suppressor Protein p53/genetics,metabolism Tumor Suppressor Proteins/genetics,metabolism
Chemicals
DNA-Binding Proteins Nuclear Proteins Protein Isoforms TP63 protein, human TP73 protein, human Trans-Activators Transcription Factors Tumor Protein p73 Tumor Suppressor Protein p53 Tumor Suppressor Proteins
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Bourdon Jean-Christophe
University of Dundee, Ninewells Hospital, Department of Surgery, CR-UK Cell Transformation Research Group, UK. [email protected]
References (20)
20 references, click to expand
  1. A transcriptionally active DNA-binding site for human p53 protein complexes.
    Mol Cell Biol. 1992 Jun;12(6):2866-71 PMID: 1588974
  2. Function of alternative splicing.
    Gene. 2005 Jan 3;344:1-20 PMID: 15656968
  3. The human tumour suppressor gene p53 is alternatively spliced in normal cells.
    Oncogene. 1996 Feb 15;12(4):813-8 PMID: 8632903
  4. Loss of function of def selectively up-regulates Delta113p53 expression to arrest expansion growth of digestive organs in zebrafish.
    Genes Dev. 2005 Dec 1;19(23):2900-11 PMID: 16322560
  5. On the road to cancer: aneuploidy and the mitotic checkpoint.
    Nat Rev Cancer. 2005 Oct;5(10):773-85 PMID: 16195750
  6. Alternative splicing of the p53 tumor suppressor gene in the Molt-4 T-lymphoblastic leukemia cell line.
    Cancer Lett. 1993 Sep 30;73(2-3):141-8 PMID: 8221626
  7. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers.
    Cell. 1997 Aug 22;90(4):809-19 PMID: 9288759
  8. p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products.
    Nat Cell Biol. 2002 Jun;4(6):462-7 PMID: 12032546
  9. WAF1, a potential mediator of p53 tumor suppression.
    Cell. 1993 Nov 19;75(4):817-25 PMID: 8242752
  10. The unique NH2-terminally deleted (DeltaN) residues, the PXXP motif, and the PPXY motif are required for the transcriptional activity of the DeltaN variant of p63.
    J Biol Chem. 2006 Feb 3;281(5):2533-42 PMID: 16319057
  11. Definition of a consensus binding site for p53.
    Nat Genet. 1992 Apr;1(1):45-9 PMID: 1301998
  12. A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint.
    Cell. 2005 Jul 15;122(1):21-32 PMID: 16009130
  13. Regulation of human p53 activity and cell localization by alternative splicing.
    Mol Cell Biol. 2004 Sep;24(18):7987-97 PMID: 15340061
  14. Further characterisation of the p53 responsive element--identification of new candidate genes for trans-activation by p53.
    Oncogene. 1997 Jan 9;14(1):85-94 PMID: 9010235
  15. Decision making by p53: life, death and cancer.
    Cell Death Differ. 2003 Apr;10(4):431-42 PMID: 12719720
  16. Cancer. p53, guardian of the genome.
    Nature. 1992 Jul 2;358(6381):15-6 PMID: 1614522
  17. A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia.
    Clin Cancer Res. 2006 Jul 1;12(13):3985-92 PMID: 16818696
  18. p53 isoforms can regulate p53 transcriptional activity.
    Genes Dev. 2005 Sep 15;19(18):2122-37 PMID: 16131611
  19. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.
    Mol Cell. 1998 Sep;2(3):305-16 PMID: 9774969
  20. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
    Cell. 1993 Nov 19;75(4):805-16 PMID: 8242751
Article Info
Journal
Current pharmaceutical biotechnology
Abbr.
Curr Pharm Biotechnol
ISSN
1873-4316
Published
2007-12-00
Pages
332-6
Language
English
Region
Netherlands
NLM ID
100960530
PMCID
PMC3523268
Subset
IM
Grants
Cancer Research UK · A6613 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]